Reliance Industries To Roll Out Genome Testing Kit Soon: Report

Mukesh Ambani-backed Reliance Industries has forayed into genome testing and its test kit will be rolled out soon. The kit is developed by the Bengaluru-based Strand Life Sciences, which was acquired by Reliance Industries in 2021 and has 80 per cent stake in the firm.
As per a report from Allied Market Research, the market for global genetic testing was valued at $12.7 billion in 2019 and is anticipated to touch $21.3 billion by 2027
Outlook covers the latest India news, analysis, business news and long-form stories on culture, money market and personal finance. Read India's best online magazine.

COVID-19 Rapid Test Kits Market Key Analysis, Size And Industry Overview 2032

TRAINING REPORT RELIANCE INDUSTRIES LIMITED AHMEDADAD GUJARAT

Sahil Patil on LinkedIn: Reliance Industries To Roll Out Genome

RIL to roll out cheapest genome sequencing kits priced $150 - Industry News

Reliance's genome test kit to launch soon, costs Rs. 12,000

Frontiers Implementation of California COVIDNet – a multi-sector collaboration for statewide SARS-CoV-2 genomic surveillance

Precise Detection of Viral RNA by Programming Multiplex Rolling Circle Amplification and Strand Displacement

Frontiers Research progress of CRISPR-based biosensors and bioassays for molecular diagnosis

Reliance India Limited